Central anticholinergic syndrome from orphenadrine in a 3 year old
Authors:
- Kevin C. OsterhoudtKOKevin C. Osterhoudt
- Richard RutsteinRRRichard Rutstein
- 1 April 2000
- journal article
- case report
- Published by Wolters Kluwer Health in Pediatric Emergency Care
- Vol. 16 (2) , 97-98
Abstract
Orphenadrine (N,N-dimethyl-2( o -methyl-alpha-phenylbenzyloxy)ethylamine) is an analog of diphenhydramine with central and peripheral anticholinergic properties. It is commonly prescribed both as a muscle relaxant and as an adjunct to antipsychotic medications to prevent parkinsonism. We report a case of orphenadrine poisoning in a 3-year-old boy following ingestion of no more than two 100-mg tablets. Central anticholinergic toxicity was prominent, manifested by hallucinations and severe agitation. Orphenadrine can cause profound toxicity in children after ingestion of small doses, and should be considered as a potential cause for acute delirium in childhood.Keywords
This publication has 6 references indexed in Scilit:
- Treatment of acute anticholinergic poisoning with physostigmineThe American Journal of Emergency Medicine, 1998
- Toxicology reviews: PhysostigminePediatric Emergency Care, 1998
- Reversal of orphenadrine-induced ventricular tachycardia with physostigmineThe Journal of Emergency Medicine, 1991
- CENTRAL ANTICHOLINERGIC SYNDROME REVERSED BY TETRAHYDROAMINACRINE (THA)Medical Journal of Australia, 1975
- ORPHENADRINE POISONINGBritish Journal of Anaesthesia, 1968